# Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients

> **NCT00940472** · PHASE2,PHASE3 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** DMMET-01
- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT00940472
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940472, "Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00940472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*